Preimplantation Genetic Testing Market - Top Companies and Manufacturers

  • Report ID: 4793
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Preimplantation Genetic Testing Landscape

    • Illumina, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer LSDX
    • Abbott
    • Natera, Inc.
    • Yikon Genomics
    • Invitae Corporation
    • Genea Energy Partners Inc.
    • Eurofins Genoma Germany GmbH
    • Genomic Prediction

Browse Key Market Insights with Data Illustration:

In the News

  • Eurofins Genoma launched niPGT-A, a non-invasive preimplantation genetic aneuploidy screening test. Preimplantation genetic testing for aneuploidy (PGT-A) enables medical professionals to determine the chromosomal makeup of in vitro fertilized (IVF) embryos

  • LifeView powered by Genomic Prediction announces the partnership of Ovation Fertility with Genomic Prediction to approve the license for the LIfeView PGT Platform for genetic testing. Through this partnership, Ovation patients will have access to cutting-edge technologies and better clinical care.


Author Credits:  Radhika Pawar


  • Report ID: 4793
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of preimplantation genetic testing is assessed at USD 2.17 billion.

The preimplantation genetic testing market size was over USD 1.97 billion in 2024 and is poised to reach USD 9.31 billion by the end of 2037, witnessing around 12.6% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of congenital disorders, rising prevalence of genetic deformity, and increasing popularity of in-vitro fertilization will boost the market growth.

North America industry is expected to be the largest with a share of about 38% by 2037, due to rising cases of infertility in the region.

The major players in the market include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., PerkinElmer LSDX, Abbott, Natera, Inc., Yikon Genomics, Invitae Corporation, Genea Energy Partners Inc., Eurofins Genoma Germany GmbH, Genomic Prediction.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample